$4.93 Billion is the total value of Artal Group S.A.'s 146 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | WW INTL INC | $535,533,000 | +15.5% | 14,818,300 | 0.0% | 10.87% | +32.7% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $326,708,000 | -21.8% | 71,178,364 | 0.0% | 6.63% | -10.2% | |
| BGNE | BEIGENE LTDsponsored adr | $291,712,000 | -1.4% | 850,000 | 0.0% | 5.92% | +13.3% | |
| SEER | SEER INC | $183,187,000 | -34.5% | 5,588,366 | 0.0% | 3.72% | -24.7% | |
| XLRN | ACCELERON PHARMA INC | $175,686,000 | -7.5% | 1,400,000 | 0.0% | 3.57% | +6.3% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $127,140,000 | +20.1% | 750,000 | 0.0% | 2.58% | +37.9% | |
| MORF | MORPHIC HLDG INC | $104,403,000 | -9.3% | 1,819,186 | 0.0% | 2.12% | +4.2% | |
| GBIO | GENERATION BIO CO | $75,702,000 | -5.5% | 2,814,191 | 0.0% | 1.54% | +8.6% | |
| INTC | INTEL CORPcall | $72,982,000 | -12.3% | 1,300,000 | 0.0% | 1.48% | +0.7% | |
| BMY | BRISTOL-MYERS SQUIBB COcall | $66,820,000 | +5.8% | 1,000,000 | 0.0% | 1.36% | +21.6% | |
| IMAB | I MABsponsored ads | $62,963,000 | +73.2% | 750,000 | 0.0% | 1.28% | +99.1% | |
| SDGR | SCHRODINGER INC | $60,295,000 | -0.9% | 797,445 | 0.0% | 1.22% | +13.9% | |
| SRRK | SCHOLAR ROCK HLDG CORP | $57,800,000 | -43.0% | 2,000,000 | 0.0% | 1.17% | -34.5% | |
| ALVR | ALLOVIR INC | $45,863,000 | -15.6% | 2,323,371 | 0.0% | 0.93% | -3.1% | |
| NTLA | INTELLIA THERAPEUTICS INC | $40,478,000 | +101.7% | 250,000 | 0.0% | 0.82% | +131.5% | |
| DNLI | DENALI THERAPEUTICS INC | $39,220,000 | +37.4% | 500,000 | 0.0% | 0.80% | +57.9% | |
| FOLD | AMICUS THERAPEUTICS INC | $36,150,000 | -2.4% | 3,750,000 | 0.0% | 0.73% | +12.1% | |
| KRYS | KRYSTAL BIOTECH INC | $34,000,000 | -11.7% | 500,000 | 0.0% | 0.69% | +1.3% | |
| AGEN | AGENUS INC | $32,940,000 | +101.8% | 6,000,000 | 0.0% | 0.67% | +132.3% | |
| KRON | KRONOS BIO INC | $31,565,000 | -18.2% | 1,317,954 | 0.0% | 0.64% | -6.0% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $29,856,000 | +46.0% | 800,000 | 0.0% | 0.61% | +67.9% | |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $24,890,000 | -11.2% | 1,000,000 | 0.0% | 0.50% | +2.0% | |
| TRILLIUM THERAPEUTICS INC | $24,250,000 | -9.7% | 2,500,000 | 0.0% | 0.49% | +3.8% | ||
| SQZ | SQZ BIOTECHNOLOGIES CO | $23,211,000 | +5.6% | 1,606,309 | 0.0% | 0.47% | +21.4% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $22,080,000 | -40.8% | 2,255,375 | 0.0% | 0.45% | -32.1% | |
| TSHA | TAYSHA GENE THERAPIES INC | $22,067,000 | +4.4% | 1,040,882 | 0.0% | 0.45% | +20.1% | |
| IKNA | IKENA ONCOLOGY INC | $21,755,000 | -50.3% | 1,549,513 | 0.0% | 0.44% | -42.8% | |
| ALBO | ALBIREO PHARMA INC | $21,108,000 | -0.2% | 600,000 | 0.0% | 0.43% | +14.4% | |
| NG | NOVAGOLD RES INC | $20,826,000 | -8.6% | 2,600,000 | 0.0% | 0.42% | +5.2% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $20,071,000 | -49.8% | 1,646,517 | 0.0% | 0.41% | -42.4% | |
| NEXI | NEXIMMUNE INC | $19,584,000 | -14.5% | 1,200,000 | 0.0% | 0.40% | -2.0% | |
| GOSS | GOSSAMER BIO INC | $19,155,000 | -12.2% | 2,358,968 | 0.0% | 0.39% | +0.8% | |
| FHTX | FOGHORN THERAPEUTICS INC | $18,360,000 | -19.0% | 1,720,720 | 0.0% | 0.37% | -7.0% | |
| APTX | APTINYX INC | $17,310,000 | -5.7% | 6,116,493 | 0.0% | 0.35% | +8.3% | |
| RPTX | REPARE THERAPEUTICS INC | $17,149,000 | +1.6% | 550,000 | 0.0% | 0.35% | +16.8% | |
| MRSN | MERSANA THERAPEUTICS INC | $16,296,000 | -16.1% | 1,200,000 | 0.0% | 0.33% | -3.5% | |
| ZYME | ZYMEWORKS INC | $15,611,000 | +9.9% | 450,000 | 0.0% | 0.32% | +26.3% | |
| BLU | BELLUS HEALTH INC NEW | $14,773,000 | -19.0% | 4,750,000 | 0.0% | 0.30% | -6.8% | |
| RLAY | RELAY THERAPEUTICS INC | $14,636,000 | +5.8% | 400,000 | 0.0% | 0.30% | +21.7% | |
| HARP | HARPOON THERAPEUTICS INC | $13,870,000 | -33.7% | 1,000,000 | 0.0% | 0.28% | -23.8% | |
| NBTX | NANOBIOTIX SAsponsored ads | $13,780,000 | -8.4% | 1,000,000 | 0.0% | 0.28% | +5.3% | |
| EVLO | EVELO BIOSCIENCES INC | $13,740,000 | +28.4% | 1,000,000 | 0.0% | 0.28% | +47.6% | |
| YMAB | Y-MABS THERAPEUTICS INC | $13,520,000 | +11.8% | 400,000 | 0.0% | 0.27% | +28.0% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $12,960,000 | -0.2% | 1,000,000 | 0.0% | 0.26% | +14.8% | |
| KURA | KURA ONCOLOGY INC | $12,510,000 | -26.2% | 600,000 | 0.0% | 0.25% | -15.3% | |
| TCRR | TCR2 THERAPEUTICS INC | $12,308,000 | -25.7% | 750,000 | 0.0% | 0.25% | -14.7% | |
| KYMR | KYMERA THERAPEUTICS INC | $12,125,000 | +24.8% | 250,000 | 0.0% | 0.25% | +43.0% | |
| DYN | DYNE THERAPEUTICS INC | $11,046,000 | +35.5% | 525,000 | 0.0% | 0.22% | +55.6% | |
| VOR | VOR BIOPHARMA INC | $10,258,000 | -56.7% | 550,000 | 0.0% | 0.21% | -50.4% | |
| OVID | OVID THERAPEUTICS INC | $9,775,000 | -2.7% | 2,500,000 | 0.0% | 0.20% | +11.2% | |
| YI | 111 INCads | $8,779,000 | -34.2% | 966,349 | 0.0% | 0.18% | -24.6% | |
| TIL | INSTIL BIO INC | $8,694,000 | -23.0% | 450,000 | 0.0% | 0.18% | -11.6% | |
| IMUX | IMMUNIC INC | $8,582,000 | -23.1% | 700,000 | 0.0% | 0.17% | -11.7% | |
| STOK | STOKE THERAPEUTICS INC | $8,415,000 | -13.3% | 250,000 | 0.0% | 0.17% | -0.6% | |
| APLT | APPLIED THERAPEUTICS INC | $8,312,000 | +10.8% | 400,000 | 0.0% | 0.17% | +27.1% | |
| SLDB | SOLID BIOSCIENCES INC | $8,235,000 | -33.8% | 2,250,000 | 0.0% | 0.17% | -24.1% | |
| DSGN | DESIGN THERAPEUTICS INC | $7,956,000 | -33.5% | 400,000 | 0.0% | 0.16% | -23.7% | |
| ACIU | AC IMMUNE SA | $7,930,000 | +4.2% | 1,000,000 | 0.0% | 0.16% | +20.1% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $7,919,000 | -39.5% | 1,803,858 | 0.0% | 0.16% | -30.3% | |
| SANA | SANA BIOTECHNOLOGY INC | $7,864,000 | -41.3% | 400,000 | 0.0% | 0.16% | -32.5% | |
| ARAV | ARAVIVE INC | $7,842,000 | -9.2% | 1,311,291 | 0.0% | 0.16% | +3.9% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $7,810,000 | -8.3% | 200,000 | 0.0% | 0.16% | +6.0% | |
| OMEG | OMEGA ALPHA SPACcl a | $7,463,000 | +0.5% | 750,000 | 0.0% | 0.15% | +15.3% | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $7,322,000 | -18.4% | 200,000 | 0.0% | 0.15% | -5.7% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $7,289,000 | -15.7% | 260,500 | 0.0% | 0.15% | -3.3% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $7,273,000 | -12.1% | 1,045,000 | 0.0% | 0.15% | +1.4% | |
| SPRO | SPERO THERAPEUTICS INC | $6,980,000 | -5.2% | 500,000 | 0.0% | 0.14% | +9.2% | |
| CFRX | CONTRAFECT CORP | $6,600,000 | -8.3% | 1,500,000 | 0.0% | 0.13% | +5.5% | |
| HOOK | HOOKIPA PHARMA INC | $5,492,000 | -31.9% | 599,616 | 0.0% | 0.11% | -21.8% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $5,337,000 | -15.1% | 593,030 | 0.0% | 0.11% | -2.7% | |
| CRDF | CARDIFF ONCOLOGY INC | $4,988,000 | -28.2% | 750,000 | 0.0% | 0.10% | -17.9% | |
| LPTX | LEAP THERAPEUTICS INC | $4,920,000 | -13.7% | 3,000,000 | 0.0% | 0.10% | -1.0% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $4,755,000 | -5.9% | 1,500,000 | 0.0% | 0.10% | +9.0% | |
| MCRB | SERES THERAPEUTICS INC | $4,770,000 | +15.8% | 200,000 | 0.0% | 0.10% | +32.9% | |
| KLDO | KALEIDO BIOSCIENCES INC | $3,724,000 | -8.1% | 500,500 | 0.0% | 0.08% | +5.6% | |
| CDAK | CODIAK BIOSCIENCES INC | $3,706,000 | +22.9% | 200,000 | 0.0% | 0.08% | +41.5% | |
| RNA | AVIDITY BIOSCIENCES INC | $3,521,000 | +13.3% | 142,500 | 0.0% | 0.07% | +29.1% | |
| MTCR | METACRINE INC | $3,515,000 | -38.7% | 924,898 | 0.0% | 0.07% | -29.7% | |
| SGTX | SIGILON THERAPEUTICS INC | $2,961,000 | -52.0% | 276,000 | 0.0% | 0.06% | -45.0% | |
| KNTE | KINNATE BIOPHARMA INC | $2,910,000 | -25.3% | 125,000 | 0.0% | 0.06% | -14.5% | |
| AXLA | AXCELLA HEALTH INC | $2,857,000 | -15.8% | 712,500 | 0.0% | 0.06% | -3.3% | |
| CGEM | CULLINAN ONCOLOGY INC | $2,575,000 | -38.2% | 100,000 | 0.0% | 0.05% | -29.7% | |
| KDNY | CHINOOK THERAPEUTICS INC | $2,549,000 | -9.1% | 180,500 | 0.0% | 0.05% | +4.0% | |
| YMTX | YUMANITY THERAPEUTICS INC | $2,533,000 | -35.6% | 217,391 | 0.0% | 0.05% | -27.1% | |
| LVTX | LAVA THERAPEUTICS NV | $2,176,000 | -28.4% | 200,000 | 0.0% | 0.04% | -18.5% | |
| CHMA | CHIASMA INC | $1,797,000 | +51.1% | 380,000 | 0.0% | 0.04% | +71.4% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,423,000 | +15.1% | 110,532 | 0.0% | 0.03% | +31.8% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $1,394,000 | +27.0% | 321,100 | 0.0% | 0.03% | +47.4% | |
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $1,145,000 | +233.8% | 79,600 | 0.0% | 0.02% | +283.3% | |
| SURF | SURFACE ONCOLOGY INC | $746,000 | -4.4% | 100,000 | 0.0% | 0.02% | +7.1% | |
| CDTX | CIDARA THERAPEUTICS INC | $454,000 | -24.1% | 224,675 | 0.0% | 0.01% | -18.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.